{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:58:35Z","timestamp":1777341515721,"version":"3.51.4"},"reference-count":27,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T00:00:00Z","timestamp":1327881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine the association between atypical antipsychotic medications and incident treatment for diabetes mellitus or hyperlipidemia in elderly adults without diagnoses of schizophrenia or bipolar disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Two case\u2013control studies using medical and pharmacy claims data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">U<\/jats:styled-content>\n                      nited\n                      <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                      tates managed care population from multiple insurance plans.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>\n                      Individuals aged 65 and older enrolled in a Medicare Advantage or commercial (health maintenance organization) managed care health plan in the western\n                      <jats:styled-content style=\"fixed-case\">U<\/jats:styled-content>\n                      nited\n                      <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                      tates with no claims indicating diagnosis of schizophrenia or bipolar disorder in the 1\u00a0year pre\u2010index period. Cases were defined as persons newly initiated on an antidiabetic (n\u00a0=\u00a013,075) or antihyperlipidemic (n\u00a0= 63,829) medication on the index date. For the new diabetes mellitus analysis, 65,375 controls were matched to cases based on age, sex, health\u2010plan type, and index date year. In the new hyperlipidemia analysis, 63,829 controls were matched to cases based on the same variables.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements<\/jats:title>\n                    <jats:p>Conditional logistic regressions were performed to determine the odds of initiated antidiabetic or antihyperlipidemic medication for participants exposed to atypical antipsychotics compared with those with no exposure. The models included comorbidities possibly associated with the outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Exposure to atypical antipsychotics was associated with significantly greater adjusted odds of starting an antidiabetic medication (1.32, 95% confidence interval (\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      )\u00a0=\u00a01.10\u20131.59) but significantly lower odds of starting an antihyperlipidemic medication (0.76, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      \u00a0=\u00a00.67\u20130.87).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Use of atypical antipsychotics in older adults for conditions other than schizophrenia and bipolar disorder was associated with incident treatment of diabetes mellitus but not of hyperlipidemia, suggesting that older adults may be susceptible to the adverse metabolic consequences of these agents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1532-5415.2011.03842.x","type":"journal-article","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T14:40:26Z","timestamp":1327934426000},"page":"474-479","source":"Crossref","is-referenced-by-count":39,"title":["New\u2010Onset Treatment\u2010Dependent Diabetes Mellitus and Hyperlipidemia Associated with Atypical Antipsychotic Use in Older Adults without Schizophrenia or Bipolar Disorder"],"prefix":"10.1111","volume":"60","author":[{"given":"Sara C.","family":"Erickson","sequence":"first","affiliation":[{"name":"OptumRx Irvine California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Le","sequence":"additional","affiliation":[{"name":"OptumRx Irvine California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armen","family":"Zakharyan","sequence":"additional","affiliation":[{"name":"OptumRx Irvine California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen M.","family":"Stockl","sequence":"additional","affiliation":[{"name":"OptumRx Irvine California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann S. M.","family":"Harada","sequence":"additional","affiliation":[{"name":"OptumRx Irvine California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo","family":"Borson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences University of Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Ramsey","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center Seattle Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford","family":"Curtis","sequence":"additional","affiliation":[{"name":"OptumRx Irvine California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,30]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.01.028"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2006.08.009"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318166c4f7"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0707"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-009-0006-0"},{"key":"e_1_2_6_7_1","first-page":"28","article-title":"Use of atypical antipsychotics in the elderly","volume":"5","author":"Cascade E","year":"2008","journal-title":"Psychiatry (Edgemont)"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2007.07.005"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.4140\/TCP.n.2009.201"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2008.08.005"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.14.1411.31939"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/10401230500464588"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.08081218"},{"key":"e_1_2_6_14_1","unstructured":"RabinsPV BlackerD RovnerBWet\u00a0al.Practice guideline for the treatment of patients with Alzheimer's disease and other dementias [on\u2010line]. Arlington (VA): American Psychiatric Association 2007. Available athttp:\/\/www.psychiatryonline.com\/pracGuide\/pracGuideTopic_3.aspx. Accessed March 5 2010."},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000095804"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90133-8"},{"key":"e_1_2_6_17_1","unstructured":"Centers for Disease Control and Prevention.Percentage of civilian noninstitutionalized population with diagnosed diabetes by age United States 1980\u20132007 [on\u2010line] July 29 2009. Available athttp:\/\/www.cdc.gov\/diabetes\/statistics\/prev\/national\/figbyage.htm. Accessed March 9 2010."},{"key":"e_1_2_6_18_1","unstructured":"American Diabetes Association.Diabetes statistics [on\u2010line]. Available athttp:\/\/www.diabetes.org\/diabetes-basics\/diabetes-statistics\/. Accessed March 9 2010."},{"key":"e_1_2_6_19_1","first-page":"769","article-title":"Incidence and outcomes of diabetes mellitus in elderly people: Report from the Canadian Study of Heath and Aging","volume":"162","author":"Rockwood K","year":"2000","journal-title":"Can Med Assoc J"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2000.00362.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.1.37"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1176\/pn.38.1.0001"},{"key":"e_1_2_6_23_1","unstructured":"U.S. Food and Drug Administration.Warning about hyperglycemia and atypical antipsychotic drugs. FDA Safety News [on\u2010line] June 2004. Available athttp:\/\/www.accessdata.fda.gov\/psn\/transcript.cfm?show=28. Accessed March 11 2010."},{"key":"e_1_2_6_24_1","first-page":"CD006654","article-title":"Olanzapine versus other atypical antipsychotics for schizophrenia","volume":"3","author":"Komossa K","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_25_1","first-page":"CD006569","article-title":"Aripiprazole versus other atypical antipsychotics for schizophrenia","volume":"4","author":"Komassa K","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.12.487"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200503000-00008"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08r04392"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1532-5415.2011.03842.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.2011.03842.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1532-5415.2011.03842.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.2011.03842.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T12:25:47Z","timestamp":1762172747000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1532-5415.2011.03842.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,30]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1111\/j.1532-5415.2011.03842.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03842.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,30]]}}}